Post-hoc analysis of injection-site reactions following vaccination with quadrivalent human papillomavirus vaccine in Japanese female clinical trial participants

Aim: The quadrivalent human papillomavirus (4vHPV) vaccine has demonstrated efficacy and immunogenicity and was generally well tolerated in clinical trials conducted in Japan. We report a detailed safety analysis of injection-site reactions in female Japanese 4vHPV clinical trial participants. Metho...

Full description

Bibliographic Details
Main Authors: Shinya Murata, Masayoshi Shirakawa, Yoshie Sugawara, Michiko Shuto, Miyuki Sawata, Yoshiyuki Tanaka
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Papillomavirus Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405852120300045